Focus: Krystal Biotech is a Pittsburgh-based gene therapy company focused on topical and systemic treatments for rare genetic diseases, particularly skin disorders and systemic conditions. The company operates as a mid-cap biotech with a concentrated pipeline in gene therapy modalities.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Hot — 112 jobs added in 30d
Net +103 (112 new, 9 removed). Aggressive expansion phase.
Krystal Biotech is a gene-therapy specialist with clinical momentum but limited financial transparency—suitable for risk-tolerant candidates seeking deep technical roles in a pre-commercial or early-commercial stage company.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Krystal Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Krystal Biotech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles